HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fluorescence in situ hybridization (FISH) for retrospective detection of trisomies 3 and 7 in multiple myeloma.

Abstract
The malignant plasma cells of multiple myeloma (MM) have a low proliferative activity and therefore cytogenetic studies of the disease have been severely limited. We evaluated the role of fluorescence in situ hybridization (FISH) in the detection of numerical chromosomal abnormalities in early stages of myeloma and the applicability of the method to stored archival slides. Old air-dried bone marrow smears from 15 myeloma patients obtained at presentation were probed with alpha satellite DNA sequences to chromosomes 3 and 7. Numerical chromosome aberrations were found in eight (53%) of the patients, including six (of 12) with trisomy 7, and two (of eight) with trisomy 3. This study demonstrates that FISH is a sensitive method for the detection of numerical aberrations in myeloma and for the study of old slides for retrospective analysis.
AuthorsR Dubinsky, A Amiel, Y Manor, Y Radnay, M Fejgin, M Ravid, M Lishner
JournalCancer genetics and cytogenetics (Cancer Genet Cytogenet) Vol. 83 Issue 2 Pg. 115-8 (Sep 1995) ISSN: 0165-4608 [Print] United States
PMID7553579 (Publication Type: Journal Article)
Chemical References
  • DNA Probes
Topics
  • Aged
  • Aged, 80 and over
  • Chromosomes, Human, Pair 3
  • Chromosomes, Human, Pair 7
  • DNA Probes
  • Female
  • Humans
  • In Situ Hybridization, Fluorescence
  • Male
  • Middle Aged
  • Multiple Myeloma (genetics)
  • Trisomy (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: